LIFE SCIENCES AND BIOTECH
Your Trusted Life Sciences Fractional CFO and Practice Leader
Kevin Sarney serves as a life science CFO for our clients. He has over 20 years of experience in public and private life science companies. His life science financial consulting expertise can help your organization prepare for and complete financial raises, financial controls, audits, SEC reports, and more. Kevin will be there to support your financial operations, from drug developments all the way to product launches.
Kevin's wealth of knowledge and expertise has allowed Tsaro, Genocea, Enumeral, and a number of other companies to go public. He is a CPA with an MBA from Boston University, an M.A. in accounting from Suffolk University, and a B.S. in management from the University of Hartford.
We are pleased to partner with executives and finance teams in the life science industry including biotech, pharma and medtech. Time after time, clients rely on our fractional and interim life science CFO and outsourced accounting services to:
Take advantage of specialized knowledge and training
Eliminate the need for headcount expansion during critical growth stages, from pre-funded start-up to post-IPO
Our life sciences financial consulting service can help you address a variety of common challenges including labor-intensive budgeting, multiple scenario planning, long-term project R&D cycles, and capital-intensive planning.
“We outsourced our complete accounting and finance function for the life of our biotech company, from inception to even after we were acquired by Celgene. Charles River CFO provided exceptional service throughout – outsourcing accounting and finance was a successful solution for us.”
Founder, and former CEO
"Charles River CFO (CRCFO) has been an excellent strategic partner with Sapphiros. Their team approach provides us with the right expertise, whether for our unique financial needs or the companies we have on our platform. CRCFO’s flexibility, depth of financial experience, and client responsiveness have proven to be a real asset to our growth."